MINOCYCLINE

MINOCYCLINE was reported 11730 times

MINOCYCLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE HYPERPIGMENTATION 56 0.6914
1 CONJUNCTIVAL PIGMENTATION 20 0.5000
2 OCHRONOSIS 33 0.4648
3 TYPE 2 LEPRA REACTION 62 0.3316
4 SCLERAL PIGMENTATION 28 0.2947
5 POLYARTERITIS NODOSA 138 0.2363
6 INTESTINAL SEPSIS 36 0.1374
7 PERIUMBILICAL ABSCESS 9 0.1343
8 FACET JOINT SYNDROME 391 0.1200
9 THYROIDITIS ACUTE 16 0.1119
10 ONYCHOMADESIS 451 0.1074
11 RHEUMATIC FEVER 414 0.0928
12 PERIPHERAL VENOUS DISEASE 349 0.0854
13 ONYCHOMYCOSIS 333 0.0758
14 LUPUS VULGARIS 93 0.0738
15 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 48 0.0719
16 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 503 0.0701
17 HYPOCHOLESTEROLAEMIA 24 0.0680
18 RETINITIS 117 0.0677
19 CONJUNCTIVAL SCAR 10 0.0662
20 OVERLAP SYNDROME 45 0.0643
21 EOSINOPHILIC PNEUMONIA ACUTE 53 0.0612
22 HEPATIC ENZYME 9 0.0604
23 C-REACTIVE PROTEIN ABNORMAL 385 0.0600
24 DUODENAL ULCER PERFORATION 438 0.0588
25 BLEPHAROSPASM 368 0.0584
26 EOSINOPHILIC MYOCARDITIS 41 0.0562
27 FINGER DEFORMITY 271 0.0559
28 BREAST CANCER STAGE III 352 0.0543
29 INFUSION SITE REACTION 158 0.0528
30 MONONEUROPATHY MULTIPLEX 24 0.0519
31 CATHETER SITE ABSCESS 9 0.0517
32 BONE EROSION 181 0.0511
33 SCLERAL DISCOLOURATION 33 0.0503
34 FOLLICULITIS 508 0.0484
35 HELICOBACTER INFECTION 484 0.0470
36 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 26 0.0463
37 SYMBLEPHARON 12 0.0460
38 NAIL DISORDER 394 0.0450
39 VASCULITIS NECROTISING 32 0.0447
40 PEMPHIGUS 550 0.0439
41 MUSCLE INJURY 363 0.0438
42 MONONEUROPATHY 9 0.0433
43 HYPERCHOLESTEROLAEMIA 409 0.0423
44 PRODUCT LABEL CONFUSION 229 0.0393
45 C-REACTIVE PROTEIN 36 0.0388
46 BACK INJURY 415 0.0381
47 GRIP STRENGTH DECREASED 330 0.0375
48 HAND DEFORMITY 485 0.0369
49 LIVE BIRTH 300 0.0358
50 BURSITIS 435 0.0358
51 MONOCYTOSIS 22 0.0354
52 SERONEGATIVE ARTHRITIS 40 0.0349
53 DEEP VEIN THROMBOSIS POSTOPERATIVE 68 0.0339
54 LIP DRY 306 0.0337
55 METAL POISONING 19 0.0328
56 SYNOVITIS 565 0.0313
57 PERICARDITIS 518 0.0308
58 LEUKAEMOID REACTION 8 0.0308
59 MYCOBACTERIUM ABSCESSUS INFECTION 22 0.0308
60 COELIAC DISEASE 299 0.0305
61 WOUND INFECTION 310 0.0283
62 DISLOCATION OF VERTEBRA 63 0.0276
63 CONGENITAL ANOMALY 211 0.0272
64 IDIOPATHIC INTRACRANIAL HYPERTENSION 61 0.0271
65 SWOLLEN JOINT COUNT INCREASED 86 0.0269
66 X-RAY ABNORMAL 47 0.0263
67 RETINAL PIGMENTATION 20 0.0254
68 RED BLOOD CELL SEDIMENTATION RATE INCREASED 275 0.0248
69 GLOSSODYNIA 553 0.0247
70 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 51 0.0246
71 RHEUMATOID FACTOR POSITIVE 142 0.0246
72 JOINT RANGE OF MOTION DECREASED 320 0.0238
73 OBESITY 372 0.0233
74 BENIGN INTRACRANIAL HYPERTENSION 29 0.0231
75 THYROIDITIS 69 0.0230
76 LUPUS-LIKE SYNDROME 208 0.0229
77 SKIN HYPERPIGMENTATION 189 0.0220
78 NORMAL PRESSURE HYDROCEPHALUS 9 0.0220
79 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 19 0.0213
80 POLYSEROSITIS 9 0.0211
81 EXOSTOSIS 191 0.0209
82 LIVER FUNCTION TEST INCREASED 448 0.0208
83 NOCARDIOSIS 52 0.0203
84 IRRITABLE BOWEL SYNDROME 433 0.0202
85 ACOUSTIC NEUROMA 8 0.0196
86 JOINT ARTHROPLASTY 35 0.0195
87 NAIL OPERATION 8 0.0193
88 CONTRAINDICATED PRODUCT ADMINISTERED 582 0.0192
89 APPARENT DEATH 69 0.0191
90 FIBROMYALGIA 457 0.0188
91 GLIOSIS 8 0.0186
92 ADVERSE REACTION 243 0.0183
93 PIGMENTATION DISORDER 110 0.0178
94 SERUM SICKNESS-LIKE REACTION 11 0.0175
95 C-REACTIVE PROTEIN INCREASED 628 0.0172
96 MECHANICAL URTICARIA 8 0.0171
97 VANISHING BILE DUCT SYNDROME 19 0.0170
98 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 42 0.0170
99 JOINT DISLOCATION 179 0.0169
100 FOOT DEFORMITY 185 0.0167
101 SYSTEMIC LUPUS ERYTHEMATOSUS 583 0.0164
102 WOUND 457 0.0163
103 DRUG-INDUCED LIVER INJURY 505 0.0161
104 NORMAL NEWBORN 87 0.0160
105 ARTERITIS 10 0.0158
106 DEATH NEONATAL 22 0.0158
107 TASTE DISORDER 313 0.0154
108 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 11 0.0150
109 OVARIAN FAILURE 8 0.0150
110 ENTEROCOCCAL SEPSIS 12 0.0148
111 TYPE 2 DIABETES MELLITUS 491 0.0146
112 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 33 0.0143
113 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15 0.0141
114 LIVER INJURY 347 0.0141
115 JARISCH-HERXHEIMER REACTION 10 0.0140
116 OSTEOARTHRITIS 588 0.0139
117 CHRONIC HEPATITIS 11 0.0136
118 PANCREATITIS RELAPSING 11 0.0134
119 TUBERCULIN TEST POSITIVE 34 0.0134
120 IMPAIRED HEALING 438 0.0133
121 HEPATITIS 340 0.0133
122 PSORIATIC ARTHROPATHY 533 0.0131
123 GAIT INABILITY 432 0.0129
124 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 69 0.0127
125 PORPHYRIA ACUTE 18 0.0125
126 PAPILLOEDEMA 54 0.0119
127 OTOTOXICITY 22 0.0119
128 EXPOSURE TO SARS-COV-2 20 0.0118
129 NIGHT SWEATS 374 0.0116
130 EPILEPSY 353 0.0115
131 AUTOIMMUNE HEPATITIS 79 0.0113
132 HIDRADENITIS 102 0.0112
133 IIIRD NERVE PARALYSIS 9 0.0111
134 INFLAMMATION 568 0.0110
135 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 282 0.0109
136 PULMONARY NOCARDIOSIS 9 0.0109
137 BLOOD CHOLESTEROL INCREASED 507 0.0109
138 FUNGAEMIA 17 0.0108
139 SUBCUTANEOUS ABSCESS 51 0.0106
140 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 68 0.0105
141 TERMINAL STATE 70 0.0105
142 OPTIC ATROPHY 17 0.0104
143 PANCREATIC PSEUDOCYST 8 0.0103
144 RED MAN SYNDROME 9 0.0102
145 INTRACRANIAL PRESSURE INCREASED 57 0.0102
146 DACTYLITIS 10 0.0102
147 THERAPEUTIC PRODUCT EFFECT DECREASED 441 0.0098
148 ACNE PUSTULAR 8 0.0098
149 ARTHROPATHY 539 0.0097
150 STENOTROPHOMONAS INFECTION 13 0.0096
151 SKIN DEPIGMENTATION 13 0.0095
152 ADRENAL SUPPRESSION 8 0.0095
153 DRUG INTOLERANCE 913 0.0094
154 ANTINUCLEAR ANTIBODY INCREASED 9 0.0094
155 AUTOIMMUNE DISORDER 91 0.0093
156 ANTIPHOSPHOLIPID SYNDROME 15 0.0093
157 POUCHITIS 8 0.0093
158 PUSTULAR PSORIASIS 31 0.0090
159 INFUSION RELATED REACTION 597 0.0090
160 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 10 0.0089
161 STOMATITIS 534 0.0088
162 HEPATIC ENZYME INCREASED 597 0.0087
163 PREMATURE MENOPAUSE 8 0.0087
164 DRUG TOLERANCE DECREASED 24 0.0085
165 ULCERATIVE KERATITIS 23 0.0084
166 SOMATIC SYMPTOM DISORDER 9 0.0083
167 NECK PAIN 464 0.0083
168 LYMPHADENITIS 20 0.0083
169 LUNG DISORDER 404 0.0082
170 BLISTER 460 0.0082
171 PAPILLARY THYROID CANCER 14 0.0080
172 PHOTOSENSITIVITY REACTION 133 0.0080
173 HYPERPARATHYROIDISM SECONDARY 20 0.0080
174 LOWER RESPIRATORY TRACT INFECTION 361 0.0079
175 WHITE MATTER LESION 10 0.0079
176 MOBILITY DECREASED 567 0.0079
177 JOINT STIFFNESS 207 0.0079
178 RHEUMATOID ARTHRITIS 879 0.0077
179 PULMONARY THROMBOSIS 83 0.0076
180 PUSTULE 18 0.0076
181 TREATMENT FAILURE 629 0.0076
182 NEPHROGENIC ANAEMIA 35 0.0075
183 SPONDYLITIS 27 0.0074
184 PHARYNGEAL INFLAMMATION 9 0.0074
185 VESTIBULAR DISORDER 9 0.0073
186 REBOUND ACID HYPERSECRETION 22 0.0073
187 JOINT SWELLING 874 0.0072
188 CHOLESTATIC LIVER INJURY 16 0.0072
189 HEPATIC CIRRHOSIS 135 0.0072
190 BRASH SYNDROME 10 0.0071
191 SLEEP DISORDER 497 0.0070
192 INJURY 492 0.0070
193 HISTOPLASMOSIS DISSEMINATED 11 0.0069
194 RADIATION SKIN INJURY 8 0.0069
195 EPIDIDYMITIS 8 0.0069
196 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 16 0.0069
197 VASCULITIS 80 0.0069
198 WALKING AID USER 45 0.0068
199 TOOTH DISCOLOURATION 20 0.0068
200 MATERNAL EXPOSURE DURING PREGNANCY 592 0.0066
201 RASH VESICULAR 32 0.0066
202 INTENTIONAL PRODUCT USE ISSUE 577 0.0066
203 DERMATITIS ACNEIFORM 40 0.0066
204 XEROSIS 8 0.0065
205 MUSCULOSKELETAL PAIN 333 0.0063
206 GASTROOESOPHAGEAL REFLUX DISEASE 510 0.0063
207 SPLENIC INFARCTION 11 0.0063
208 PROTEIN TOTAL ABNORMAL 8 0.0061
209 CYSTIC FIBROSIS 34 0.0061
210 GENERAL PHYSICAL HEALTH DETERIORATION 693 0.0060
211 SPINAL FUSION SURGERY 24 0.0059
212 BREAST CANCER STAGE II 49 0.0059
213 ANTINUCLEAR ANTIBODY POSITIVE 19 0.0058
214 PYODERMA GANGRENOSUM 21 0.0058
215 WOUND COMPLICATION 20 0.0058
216 OPHTHALMOPLEGIA 9 0.0057
217 LYME DISEASE 19 0.0057
218 TESTICULAR PAIN 18 0.0057
219 APPLICATION SITE DISCOLOURATION 23 0.0057
220 THROMBOPHLEBITIS SUPERFICIAL 17 0.0056
221 HYPERTHYROIDISM 81 0.0056
222 OSTEOPOROSIS 230 0.0056
223 EXPOSURE DURING PREGNANCY 345 0.0055
224 VENOUS THROMBOSIS LIMB 11 0.0053
225 MUSCULOSKELETAL STIFFNESS 464 0.0053
226 AUTOIMMUNE THYROIDITIS 20 0.0053
227 SWELLING 492 0.0053
228 WHEEZING 311 0.0052
229 PANCREATIC CYST 10 0.0052
230 ORAL MUCOSAL ERYTHEMA 8 0.0052
231 DRY MOUTH 419 0.0052
232 MULTIPLE-DRUG RESISTANCE 16 0.0052
233 ILL-DEFINED DISORDER 310 0.0051
234 NAIL DISCOLOURATION 20 0.0051
235 CONJUNCTIVAL HYPERAEMIA 18 0.0050
236 ULCER HAEMORRHAGE 34 0.0050
237 SCIATICA 79 0.0050
238 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 352 0.0049
239 EYE INJURY 15 0.0049
240 ROSACEA 23 0.0049
241 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
242 DYSPEPSIA 470 0.0048
243 END STAGE RENAL DISEASE 87 0.0048
244 POLYARTHRITIS 25 0.0047
245 INJECTION SITE REACTION 325 0.0047
246 KNEE ARTHROPLASTY 99 0.0047
247 AMYLOIDOSIS 8 0.0046
248 HENOCH-SCHONLEIN PURPURA 10 0.0046
249 GASTROINTESTINAL DISORDER 405 0.0045
250 FEAR OF DISEASE 8 0.0045
251 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 216 0.0045
252 FINE MOTOR SKILL DYSFUNCTION 13 0.0045
253 EOSINOPHILIC PNEUMONIA 14 0.0044
254 B-CELL LYMPHOMA 15 0.0044
255 SKIN INDURATION 9 0.0043
256 PRE-EXISTING CONDITION IMPROVED 27 0.0043
257 EXFOLIATIVE RASH 11 0.0042
258 MONOCYTE COUNT INCREASED 15 0.0041
259 PEMPHIGOID 31 0.0041
260 MUSCULAR WEAKNESS 466 0.0041
261 PRESCRIBED OVERDOSE 79 0.0041
262 TYPE IV HYPERSENSITIVITY REACTION 11 0.0040
263 MATERNAL EXPOSURE TIMING UNSPECIFIED 15 0.0040
264 HYPOAESTHESIA 588 0.0039
265 ABDOMINAL DISTENSION 406 0.0039
266 CHEST INJURY 8 0.0039
267 WOUND SECRETION 15 0.0038
268 LIVEDO RETICULARIS 8 0.0038
269 LOWER LIMB FRACTURE 72 0.0037
270 ABDOMINAL DISCOMFORT 623 0.0037
271 URTICARIA 614 0.0037
272 MELANOCYTIC NAEVUS 16 0.0036
273 ORGANISING PNEUMONIA 18 0.0036
274 PULMONARY FIBROSIS 69 0.0036
275 EAR INFECTION 95 0.0036
276 SKIN ODOUR ABNORMAL 14 0.0036
277 SKIN PLAQUE 30 0.0036
278 PAPULE 25 0.0035
279 SKIN TOXICITY 20 0.0035
280 HIP ARTHROPLASTY 54 0.0035
281 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 26 0.0035
282 ERYTHEMA NODOSUM 12 0.0034
283 PANCREATITIS CHRONIC 8 0.0034
284 PERIPHERAL SWELLING 519 0.0034
285 STENT PLACEMENT 27 0.0033
286 DEAFNESS NEUROSENSORY 11 0.0033
287 CONFUSIONAL STATE 537 0.0033
288 MIGRAINE 317 0.0033
289 PATHOGEN RESISTANCE 30 0.0033
290 ABSCESS LIMB 14 0.0033
291 DIVERTICULITIS 91 0.0033
292 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 56 0.0033
293 HYPERTRIGLYCERIDAEMIA 19 0.0032
294 CHRONIC KIDNEY DISEASE 244 0.0032
295 HYPERTENSION 675 0.0032
296 OESOPHAGEAL STENOSIS 9 0.0032
297 BRAIN ABSCESS 8 0.0032
298 PRESCRIBED UNDERDOSE 63 0.0032
299 TUBULOINTERSTITIAL NEPHRITIS 59 0.0031
300 SKIN MASS 21 0.0031
301 MENINGITIS ASEPTIC 14 0.0031
302 SUSPECTED OFF LABEL USE 14 0.0031
303 ACTINIC KERATOSIS 8 0.0031
304 ARTHRITIS 241 0.0031
305 CARDIOVASCULAR DISORDER 77 0.0030
306 GASTRIC DISORDER 103 0.0030
307 DRUG RESISTANCE 77 0.0030
308 AREFLEXIA 8 0.0030
309 TYPE 1 DIABETES MELLITUS 18 0.0030
310 PARAESTHESIA 467 0.0030
311 EOSINOPHILIA 52 0.0030
312 ALOPECIA 575 0.0029
313 MEMORY IMPAIRMENT 398 0.0029
314 MACULE 8 0.0029
315 EYE INFLAMMATION 27 0.0028
316 PERONEAL NERVE PALSY 16 0.0028
317 MYOCARDITIS 32 0.0028
318 DISCOMFORT 170 0.0028
319 OCULAR ICTERUS 12 0.0028
320 DRUG TOLERANCE 14 0.0028
321 TOOTH INJURY 12 0.0028
322 NEGATIVE THOUGHTS 8 0.0027
323 NASOPHARYNGITIS 502 0.0027
324 HISTIOCYTOSIS HAEMATOPHAGIC 8 0.0027
325 HYPERSENSITIVITY 498 0.0027
326 ACNE CYSTIC 8 0.0027
327 THERAPY PARTIAL RESPONDER 41 0.0026
328 ANAL ABSCESS 14 0.0026
329 PRODUCT RESIDUE PRESENT 14 0.0026
330 MUSCLE SPASMS 476 0.0026
331 CHEILITIS 14 0.0026
332 INTERSTITIAL LUNG DISEASE 125 0.0026
333 DEPRESSION 586 0.0026
334 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 141 0.0026
335 INFLAMMATORY BOWEL DISEASE 25 0.0026
336 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
337 ADVERSE DRUG REACTION 226 0.0025
338 SKIN DISCOLOURATION 115 0.0025
339 INCORRECT PRODUCT ADMINISTRATION DURATION 54 0.0025
340 CONDITION AGGRAVATED 755 0.0025
341 EAR PAIN 48 0.0025
342 THERAPY NON-RESPONDER 110 0.0024
343 DEMYELINATION 10 0.0024
344 DEEP VEIN THROMBOSIS 158 0.0024
345 PRODUCT USE IN UNAPPROVED INDICATION 601 0.0024
346 ARTERIOSCLEROSIS CORONARY ARTERY 16 0.0024
347 ARTHRALGIA 1003 0.0024
348 SKIN LESION 66 0.0024
349 THYROID DISORDER 37 0.0024
350 ABDOMINAL PAIN UPPER 492 0.0024
351 DISABILITY 47 0.0024
352 RASH PUSTULAR 17 0.0023
353 PRODUCT QUALITY ISSUE 316 0.0023
354 PNEUMONIA 750 0.0023
355 TENDERNESS 24 0.0023
356 PULMONARY FUNCTION TEST DECREASED 10 0.0023
357 EAR PRURITUS 8 0.0023
358 BACTERAEMIA 27 0.0023
359 LEUKOCYTOSIS 41 0.0023
360 NYSTAGMUS 12 0.0023
361 SLEEP APNOEA SYNDROME 43 0.0023
362 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
363 PULMONARY EMBOLISM 211 0.0022
364 DERMATITIS EXFOLIATIVE 11 0.0022
365 GOITRE 9 0.0022
366 THROMBOCYTOSIS 8 0.0022
367 DEAFNESS UNILATERAL 12 0.0022
368 PRODUCT USE ISSUE 405 0.0022
369 ACUTE KIDNEY INJURY 329 0.0021
370 RENAL TUBULAR NECROSIS 21 0.0021
371 MYOSITIS 19 0.0021
372 SENSORY LOSS 17 0.0021
373 CONTUSION 202 0.0021
374 RASH 911 0.0021
375 HERPES ZOSTER 120 0.0021
376 FOETAL EXPOSURE DURING PREGNANCY 169 0.0021
377 PAIN IN EXTREMITY 605 0.0021
378 ACUTE HEPATIC FAILURE 28 0.0020
379 SCAR 35 0.0020
380 ROAD TRAFFIC ACCIDENT 85 0.0020
381 HYPERTRANSAMINASAEMIA 14 0.0020
382 GENERAL SYMPTOM 15 0.0020
383 HEPATITIS CHOLESTATIC 12 0.0020
384 ACNE 151 0.0020
385 INSOMNIA 523 0.0020
386 DELIRIUM 68 0.0020
387 RENAL FAILURE 260 0.0020
388 MULTIPLE ORGAN DYSFUNCTION SYNDROME 55 0.0019
389 NASAL DRYNESS 12 0.0019
390 SQUAMOUS CELL CARCINOMA 18 0.0019
391 ORAL DISORDER 14 0.0019
392 RESPIRATORY DISORDER 57 0.0019
393 INFECTION 274 0.0019
394 FURUNCLE 15 0.0019
395 SKIN WARM 11 0.0019
396 FACIAL PARALYSIS 16 0.0019
397 ADVERSE EVENT 172 0.0019
398 ANAL FISSURE 10 0.0019
399 PNEUMONIA BACTERIAL 17 0.0019
400 NODULE 24 0.0018
401 ASPERGILLUS INFECTION 12 0.0018
402 PARONYCHIA 8 0.0018
403 MADAROSIS 21 0.0018
404 LYMPHADENOPATHY 64 0.0018
405 CHOLECYSTITIS CHRONIC 12 0.0018
406 ANAPHYLACTIC REACTION 99 0.0018
407 HAEMOLYTIC ANAEMIA 16 0.0018
408 WEIGHT INCREASED 398 0.0018
409 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
410 SARS-COV-2 TEST POSITIVE 23 0.0017
411 UNDERDOSE 127 0.0017
412 OFF LABEL USE 1492 0.0017
413 HAIR DISORDER 14 0.0017
414 SKIN ABRASION 8 0.0017
415 CYST 21 0.0017
416 CARDIAC TAMPONADE 8 0.0017
417 PAIN 1022 0.0017
418 HIP SURGERY 9 0.0017
419 EAR DISCOMFORT 17 0.0017
420 CARPAL TUNNEL SYNDROME 23 0.0016
421 MAJOR DEPRESSION 12 0.0016
422 POSTOPERATIVE WOUND INFECTION 11 0.0016
423 PRODUCT PHYSICAL CONSISTENCY ISSUE 9 0.0016
424 UPPER RESPIRATORY TRACT INFECTION 75 0.0016
425 HYPERVOLAEMIA 8 0.0016
426 OEDEMA PERIPHERAL 197 0.0016
427 PULMONARY MASS 24 0.0016
428 HAIR COLOUR CHANGES 20 0.0016
429 OEDEMA 87 0.0016
430 POST PROCEDURAL INFECTION 13 0.0016
431 ANHEDONIA 42 0.0016
432 TENDON PAIN 12 0.0016
433 OSTEOPENIA 24 0.0016
434 DECREASED APPETITE 367 0.0016
435 BRONCHITIS 116 0.0016
436 SKIN DISORDER 52 0.0016
437 RETINAL HAEMORRHAGE 11 0.0015
438 IMMUNODEFICIENCY 23 0.0015
439 HEPATITIS ACUTE 10 0.0015
440 BACK DISORDER 25 0.0015
441 TENDON DISORDER 10 0.0015
442 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
443 DERMATITIS 32 0.0015
444 PANCYTOPENIA 85 0.0015
445 FREQUENT BOWEL MOVEMENTS 41 0.0015
446 BLOOD IRON DECREASED 18 0.0015
447 GALLBLADDER DISORDER 27 0.0015
448 VISUAL IMPAIRMENT 187 0.0015
449 DRUG INEFFECTIVE 1982 0.0015
450 DIPLOPIA 39 0.0015
451 FOOD POISONING 8 0.0015
452 POST-TRAUMATIC STRESS DISORDER 10 0.0015
453 SEPSIS 166 0.0015
454 RENAL INJURY 44 0.0015
455 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
456 MUSCLE SPASTICITY 18 0.0015
457 HEPATIC FAILURE 44 0.0015
458 PNEUMOTHORAX 23 0.0014
459 SINUSITIS 147 0.0014
460 ALANINE AMINOTRANSFERASE INCREASED 88 0.0014
461 ANGIOPATHY 8 0.0014
462 NEPHROPATHY TOXIC 16 0.0014
463 COLECTOMY 8 0.0014
464 DERMATITIS CONTACT 16 0.0014
465 MALAISE 615 0.0014
466 CARDIAC VALVE DISEASE 8 0.0014
467 AFFECTIVE DISORDER 11 0.0014
468 STAPHYLOCOCCAL INFECTION 46 0.0014
469 TRANSAMINASES INCREASED 31 0.0014
470 ASTHENIA 524 0.0014
471 MYOPATHY 12 0.0014
472 DERMATITIS BULLOUS 10 0.0014
473 RESTLESS LEGS SYNDROME 25 0.0014
474 GENERALISED OEDEMA 17 0.0014
475 FALL 457 0.0014
476 SPINAL DISORDER 13 0.0014
477 SPINAL OSTEOARTHRITIS 12 0.0014
478 NAUSEA 1079 0.0014
479 DIZZINESS 679 0.0014
480 MASS 19 0.0014
481 NEUROPATHY PERIPHERAL 129 0.0014
482 LABORATORY TEST ABNORMAL 40 0.0014
483 SKIN REACTION 19 0.0013
484 HEPATOTOXICITY 30 0.0013
485 THROMBOSIS 108 0.0013
486 HAEMOGLOBIN DECREASED 136 0.0013
487 COLITIS ULCERATIVE 59 0.0013
488 BONE DISORDER 24 0.0013
489 PAIN OF SKIN 35 0.0013
490 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22 0.0013
491 ERYTHEMA MULTIFORME 12 0.0013
492 LIVER DISORDER 57 0.0013
493 HEADACHE 805 0.0013
494 MOTOR DYSFUNCTION 13 0.0013
495 INFUSION SITE SWELLING 8 0.0013
496 ASTHMA 143 0.0013
497 ABSCESS 20 0.0013
498 FISTULA 14 0.0012
499 LUNG INFILTRATION 11 0.0012
500 FACE OEDEMA 21 0.0012
501 PROCTALGIA 8 0.0012
502 INCOHERENT 8 0.0012
503 FATIGUE 962 0.0012
504 MYOCARDIAL ISCHAEMIA 14 0.0012
505 ASPARTATE AMINOTRANSFERASE INCREASED 65 0.0012
506 VOMITING 573 0.0012
507 CEREBRAL DISORDER 9 0.0012
508 PANCREATITIS ACUTE 27 0.0012
509 LOCALISED INFECTION 29 0.0012
510 RESPIRATORY FAILURE 87 0.0012
511 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
512 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
513 BRONCHIECTASIS 8 0.0012
514 BLOOD BILIRUBIN INCREASED 32 0.0012
515 TOOTH ABSCESS 12 0.0012
516 RASH ERYTHEMATOUS 56 0.0012
517 RASH MACULO-PAPULAR 26 0.0012
518 DIARRHOEA 753 0.0012
519 PSEUDOMONAS INFECTION 10 0.0012
520 RESPIRATION ABNORMAL 8 0.0012
521 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
522 PSYCHOLOGICAL TRAUMA 10 0.0012
523 HYPERBILIRUBINAEMIA 12 0.0012
524 LYMPHOEDEMA 8 0.0012
525 PYREXIA 400 0.0012
526 THERAPEUTIC RESPONSE DECREASED 70 0.0012
527 JAUNDICE 31 0.0012
528 SEPTIC SHOCK 50 0.0011
529 ACUTE RESPIRATORY FAILURE 22 0.0011
530 LEUKOPENIA 57 0.0011
531 CHOLECYSTECTOMY 13 0.0011
532 AMNESIA 74 0.0011
533 TACHYCARDIA 101 0.0011
534 TENDON RUPTURE 14 0.0011
535 IMMUNOSUPPRESSION 10 0.0011
536 RENAL CYST 9 0.0011
537 CONJUNCTIVITIS 21 0.0011
538 PULMONARY TOXICITY 8 0.0011
539 PHARYNGITIS 14 0.0011
540 BLOOD ALKALINE PHOSPHATASE INCREASED 28 0.0011
541 HYPOTHYROIDISM 36 0.0011
542 SENSORY DISTURBANCE 18 0.0011
543 MYASTHENIA GRAVIS 9 0.0011
544 SPLENOMEGALY 13 0.0011
545 OVARIAN CYST 11 0.0011
546 MULTI-ORGAN FAILURE 19 0.0011
547 PREGNANCY 22 0.0011
548 HYPERAESTHESIA 9 0.0011
549 ASCITES 32 0.0011
550 HYPOMAGNESAEMIA 15 0.0011
551 HAEMOPTYSIS 30 0.0011
552 PSORIASIS 140 0.0011
553 ADRENAL INSUFFICIENCY 13 0.0011
554 LIVER FUNCTION TEST ABNORMAL 31 0.0011
555 REBOUND EFFECT 12 0.0011
556 PANCREATITIS 56 0.0011
557 FOOT FRACTURE 20 0.0011
558 HEPATIC FUNCTION ABNORMAL 39 0.0010
559 SKIN ULCER 27 0.0010
560 ATELECTASIS 10 0.0010
561 ANKLE FRACTURE 16 0.0010
562 RASH PRURITIC 56 0.0010
563 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
564 DYSPNOEA 581 0.0010
565 SPINAL PAIN 12 0.0010
566 TINNITUS 47 0.0010
567 PULMONARY HAEMORRHAGE 8 0.0010
568 FUNGAL INFECTION 34 0.0010
569 PHARYNGITIS STREPTOCOCCAL 11 0.0010
570 SKIN LACERATION 11 0.0010
571 FACIAL PAIN 9 0.0010
572 ANXIETY 286 0.0010
573 FLUID RETENTION 51 0.0010
574 GASTRIC ULCER 19 0.0010
575 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
576 DENTAL CARIES 11 0.0010
577 TOOTHACHE 18 0.0010
578 OSTEOMYELITIS 18 0.0010
579 FRUSTRATION TOLERANCE DECREASED 8 0.0010
580 ECONOMIC PROBLEM 15 0.0010
581 STEVENS-JOHNSON SYNDROME 22 0.0010
582 NERVE INJURY 11 0.0010
583 PANIC ATTACK 36 0.0010
584 ORAL CANDIDIASIS 13 0.0010
585 TREATMENT NONCOMPLIANCE 54 0.0010
586 SINUS TACHYCARDIA 14 0.0010
587 RETCHING 21 0.0010
588 SKIN INFECTION 11 0.0010
589 POLYURIA 8 0.0010
590 EYE HAEMORRHAGE 13 0.0010
591 IMPAIRED QUALITY OF LIFE 14 0.0010
592 EYE DISORDER 32 0.0010
593 ESCHERICHIA INFECTION 8 0.0010
594 MENTAL STATUS CHANGES 27 0.0010
595 TEMPERATURE INTOLERANCE 10 0.0010
596 KIDNEY INFECTION 19 0.0010
597 LUNG INFECTION 15 0.0010
598 RENAL IMPAIRMENT 81 0.0010
599 CYTOMEGALOVIRUS INFECTION 16 0.0010
600 SINUS CONGESTION 13 0.0010
601 DRUG ERUPTION 17 0.0010
602 PHOTOPHOBIA 18 0.0010
603 THROMBOCYTOPENIA 107 0.0010
604 WEIGHT FLUCTUATION 10 0.0010
605 BLOOD PRESSURE ABNORMAL 19 0.0010
606 DERMATITIS ALLERGIC 12 0.0010
607 CYANOSIS 15 0.0010
608 ISCHAEMIC STROKE 17 0.0010
609 SPUTUM DISCOLOURED 9 0.0009
610 SKIN HAEMORRHAGE 14 0.0009
611 HYPERKALAEMIA 33 0.0009
612 CHOLESTASIS 18 0.0009
613 PLEURAL EFFUSION 57 0.0009
614 SKIN EXFOLIATION 79 0.0009
615 PRURITUS 359 0.0009
616 CHROMATURIA 21 0.0009
617 DISEASE RECURRENCE 44 0.0009
618 CHOLECYSTITIS 11 0.0009
619 SKIN SWELLING 8 0.0009
620 NEOPLASM MALIGNANT 61 0.0009
621 WEIGHT DECREASED 255 0.0009
622 CHEST PAIN 169 0.0009
623 GASTRITIS 24 0.0009
624 CARDIOGENIC SHOCK 13 0.0009
625 TENDONITIS 14 0.0009
626 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
627 BRAIN INJURY 9 0.0009
628 FEELING HOT 55 0.0009
629 ORAL PAIN 20 0.0009
630 ABDOMINAL PAIN 207 0.0009
631 RECTAL HAEMORRHAGE 38 0.0009
632 BLINDNESS 36 0.0009
633 POOR QUALITY SLEEP 19 0.0009
634 PNEUMONITIS 24 0.0009
635 HYPOXIA 31 0.0009
636 RED BLOOD CELL COUNT DECREASED 25 0.0009
637 SKIN IRRITATION 40 0.0009
638 GAIT DISTURBANCE 167 0.0009
639 INCREASED TENDENCY TO BRUISE 8 0.0009
640 UROSEPSIS 8 0.0009
641 NERVE COMPRESSION 8 0.0009
642 HYPOACUSIS 37 0.0009
643 OVERDOSE 185 0.0009
644 ROTATOR CUFF SYNDROME 11 0.0009
645 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
646 ATAXIA 10 0.0008
647 HAEMATOTOXICITY 8 0.0008
648 TOOTH INFECTION 11 0.0008
649 DECREASED ACTIVITY 9 0.0008
650 EYE PAIN 47 0.0008
651 MENSTRUATION DELAYED 9 0.0008
652 MEDICATION ERROR 46 0.0008
653 MYALGIA 140 0.0008
654 HAIR TEXTURE ABNORMAL 11 0.0008
655 CIRCULATORY COLLAPSE 14 0.0008
656 VITAMIN D DEFICIENCY 8 0.0008
657 QUALITY OF LIFE DECREASED 11 0.0008
658 OXYGEN SATURATION DECREASED 46 0.0008
659 ULCER 13 0.0008
660 FEELING ABNORMAL 195 0.0008
661 DEAFNESS 21 0.0008
662 LOCAL SWELLING 14 0.0008
663 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
664 DRY SKIN 106 0.0008
665 CELLULITIS 40 0.0008
666 FRACTURE 15 0.0008
667 MANIA 13 0.0008
668 SCAB 9 0.0008
669 DRUG LEVEL DECREASED 8 0.0008
670 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
671 NEPHROLITHIASIS 36 0.0008
672 SEROTONIN SYNDROME 15 0.0008
673 SEASONAL ALLERGY 11 0.0008
674 HEPATOCELLULAR INJURY 11 0.0008
675 SUICIDAL IDEATION 71 0.0008
676 ENCEPHALOPATHY 19 0.0008
677 EYE DISCHARGE 8 0.0008
678 UNEVALUABLE EVENT 58 0.0008
679 BRAIN FOG 12 0.0008
680 DRY EYE 38 0.0008
681 DERMATITIS ATOPIC 40 0.0008
682 WHITE BLOOD CELL COUNT INCREASED 29 0.0008
683 PARANOIA 13 0.0008
684 HYPERLIPIDAEMIA 9 0.0008
685 IMPAIRED WORK ABILITY 16 0.0007
686 MENTAL IMPAIRMENT 18 0.0007
687 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
688 TACHYPNOEA 10 0.0007
689 ASPIRATION 8 0.0007
690 LACRIMATION INCREASED 22 0.0007
691 OROPHARYNGEAL PAIN 67 0.0007
692 CYSTITIS 23 0.0007
693 VIRAL INFECTION 24 0.0007
694 SECRETION DISCHARGE 9 0.0007
695 MOVEMENT DISORDER 23 0.0007
696 HYPOKALAEMIA 33 0.0007
697 RASH PAPULAR 16 0.0007
698 PRODUCTIVE COUGH 34 0.0007
699 MUSCLE ATROPHY 9 0.0007
700 MENSTRUATION IRREGULAR 19 0.0007
701 EYE INFECTION 8 0.0007
702 EJECTION FRACTION DECREASED 11 0.0007
703 HOSPITALISATION 108 0.0007
704 ABORTION SPONTANEOUS 28 0.0007
705 SHOCK 16 0.0007
706 GASTRIC HAEMORRHAGE 8 0.0007
707 HIATUS HERNIA 9 0.0007
708 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
709 BLOOD SODIUM DECREASED 13 0.0007
710 VERTIGO 42 0.0007
711 EYELID OEDEMA 8 0.0007
712 HYPOCALCAEMIA 13 0.0007
713 DEHYDRATION 91 0.0007
714 RIB FRACTURE 14 0.0007
715 EMOTIONAL DISTRESS 82 0.0007
716 BURNING SENSATION 47 0.0007
717 COGNITIVE DISORDER 31 0.0007
718 UVEITIS 9 0.0007
719 LIMB INJURY 18 0.0007
720 SWELLING FACE 43 0.0007
721 DISEASE PROGRESSION 78 0.0007
722 NOCTURIA 8 0.0007
723 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
724 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
725 JOINT INJURY 14 0.0007
726 ERYTHEMA 134 0.0007
727 SKIN CANCER 14 0.0006
728 DRUG INTERACTION 103 0.0006
729 APPLICATION SITE ERYTHEMA 17 0.0006
730 AGRANULOCYTOSIS 12 0.0006
731 BLOOD CREATININE INCREASED 42 0.0006
732 DIABETES MELLITUS 49 0.0006
733 BASAL CELL CARCINOMA 10 0.0006
734 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
735 ANAEMIA 121 0.0006
736 CRYING 23 0.0006
737 ABDOMINAL PAIN LOWER 16 0.0006
738 BLOOD PRESSURE DECREASED 42 0.0006
739 ECZEMA 33 0.0006
740 NEUROTOXICITY 11 0.0006
741 RASH GENERALISED 16 0.0006
742 LACTIC ACIDOSIS 20 0.0006
743 MOUTH ULCERATION 13 0.0006
744 NEURALGIA 15 0.0006
745 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
746 SEIZURE 71 0.0006
747 SKIN BURNING SENSATION 44 0.0006
748 SURGERY 36 0.0006
749 DISTURBANCE IN ATTENTION 33 0.0006
750 GASTROENTERITIS VIRAL 11 0.0006
751 CARDIOMYOPATHY 9 0.0006
752 NERVOUS SYSTEM DISORDER 19 0.0006
753 SINUS DISORDER 12 0.0006
754 DRUG EFFECT INCOMPLETE 22 0.0006
755 DYSURIA 22 0.0006
756 BLOOD UREA INCREASED 10 0.0006
757 PRODUCT PRESCRIBING ISSUE 13 0.0006
758 MOOD SWINGS 19 0.0006
759 HYPERSOMNIA 17 0.0006
760 CANDIDA INFECTION 10 0.0006
761 HEPATIC STEATOSIS 11 0.0006
762 MYOCARDIAL INFARCTION 103 0.0006
763 BODY TEMPERATURE INCREASED 12 0.0006
764 HAEMATURIA 20 0.0006
765 LYMPHOMA 9 0.0006
766 CHILLS 68 0.0006
767 VAGINAL HAEMORRHAGE 25 0.0006
768 INCREASED APPETITE 11 0.0006
769 TOXICITY TO VARIOUS AGENTS 97 0.0006
770 URINARY INCONTINENCE 17 0.0006
771 CONSTIPATION 125 0.0006
772 RASH MACULAR 20 0.0006
773 DYSPHAGIA 54 0.0006
774 BALANCE DISORDER 49 0.0006
775 LYMPHOPENIA 8 0.0006
776 HEAD DISCOMFORT 10 0.0006
777 SKIN FISSURES 11 0.0006
778 THIRST 10 0.0006
779 SUBDURAL HAEMATOMA 8 0.0006
780 FEBRILE NEUTROPENIA 37 0.0006
781 PARAESTHESIA ORAL 8 0.0006
782 COUGH 155 0.0006
783 MENTAL DISORDER 24 0.0006
784 PELVIC PAIN 10 0.0005
785 GASTROENTERITIS 8 0.0005
786 OSTEONECROSIS 18 0.0005
787 OCULAR HYPERAEMIA 26 0.0005
788 RESPIRATORY DISTRESS 15 0.0005
789 FEEDING DISORDER 11 0.0005
790 EXPIRED PRODUCT ADMINISTERED 18 0.0005
791 LIP SWELLING 18 0.0005
792 TOOTH DISORDER 12 0.0005
793 CATARACT 32 0.0005
794 COLON CANCER 8 0.0005
795 SOMNOLENCE 108 0.0005
796 BACTERIAL INFECTION 10 0.0005
797 MIDDLE INSOMNIA 10 0.0005
798 HEART RATE INCREASED 53 0.0005
799 DYSARTHRIA 20 0.0005
800 PERITONITIS 11 0.0005
801 DYSPNOEA EXERTIONAL 20 0.0005
802 INTESTINAL OBSTRUCTION 20 0.0005
803 BLOOD PRESSURE INCREASED 81 0.0005
804 BLOOD COUNT ABNORMAL 8 0.0005
805 WITHDRAWAL SYNDROME 22 0.0005
806 POST PROCEDURAL COMPLICATION 10 0.0005
807 MUSCLE TWITCHING 12 0.0005
808 HERNIA 10 0.0005
809 VISION BLURRED 71 0.0005
810 MUSCULOSKELETAL CHEST PAIN 8 0.0005
811 ERUCTATION 10 0.0005
812 DELUSION 8 0.0005
813 METASTASES TO LIVER 9 0.0005
814 DYSGEUSIA 38 0.0005
815 EYE SWELLING 19 0.0005
816 BONE DENSITY DECREASED 16 0.0005
817 MENORRHAGIA 10 0.0005
818 LYMPHOCYTE COUNT DECREASED 9 0.0005
819 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
820 HYPOTENSION 101 0.0005
821 FEELING COLD 14 0.0005
822 HAEMATOMA 13 0.0005
823 METABOLIC ACIDOSIS 16 0.0005
824 NEUTROPENIA 68 0.0005
825 BLOOD PRESSURE FLUCTUATION 12 0.0005
826 RESPIRATORY TRACT INFECTION 13 0.0005
827 APHASIA 15 0.0005
828 BONE PAIN 29 0.0005
829 MUSCLE TIGHTNESS 8 0.0005
830 BONE MARROW FAILURE 10 0.0005
831 GASTROINTESTINAL HAEMORRHAGE 41 0.0005
832 SYNCOPE 49 0.0005
833 CHEST DISCOMFORT 50 0.0005
834 MULTIPLE FRACTURES 8 0.0005
835 EYE IRRITATION 28 0.0005
836 AGEUSIA 12 0.0005
837 RHABDOMYOLYSIS 20 0.0005
838 BACK PAIN 111 0.0005
839 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
840 PROTEINURIA 9 0.0005
841 DEPRESSED MOOD 25 0.0005
842 RESPIRATORY ARREST 13 0.0005
843 HAEMATOCHEZIA 26 0.0005
844 ABNORMAL DREAMS 13 0.0005
845 HYPOPHAGIA 12 0.0005
846 LETHARGY 27 0.0005
847 METRORRHAGIA 8 0.0005
848 THROAT IRRITATION 21 0.0005
849 GLAUCOMA 9 0.0005
850 HYPERGLYCAEMIA 17 0.0005
851 MUSCULOSKELETAL DISCOMFORT 8 0.0005
852 URINARY TRACT INFECTION 79 0.0005
853 PRURITUS GENERALISED 10 0.0005
854 SUICIDE ATTEMPT 28 0.0005
855 HAEMORRHOIDS 9 0.0005
856 ORAL HERPES 9 0.0005
857 MUCOSAL INFLAMMATION 12 0.0005
858 MELAENA 10 0.0005
859 APPLICATION SITE PAIN 10 0.0005
860 ANGIOEDEMA 20 0.0005
861 SPINAL FRACTURE 9 0.0004
862 SWOLLEN TONGUE 14 0.0004
863 THERAPY CESSATION 23 0.0004
864 RENAL FAILURE ACUTE 19 0.0004
865 PULMONARY OEDEMA 20 0.0004
866 DYSSTASIA 13 0.0004
867 DYSPHONIA 26 0.0004
868 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
869 NEUTROPHIL COUNT DECREASED 18 0.0004
870 COVID-19 77 0.0004
871 CARDIAC ARREST 36 0.0004
872 WHITE BLOOD CELL COUNT DECREASED 47 0.0004
873 PERICARDIAL EFFUSION 10 0.0004
874 HYPERHIDROSIS 55 0.0004
875 PALPITATIONS 50 0.0004
876 CHOLELITHIASIS 14 0.0004
877 NASAL CONGESTION 25 0.0004
878 COLITIS 16 0.0004
879 MUSCULOSKELETAL DISORDER 8 0.0004
880 LIMB DISCOMFORT 13 0.0004
881 DYSKINESIA 17 0.0004
882 ANGER 14 0.0004
883 PRODUCT DOSE OMISSION 27 0.0004
884 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
885 MALIGNANT NEOPLASM PROGRESSION 42 0.0004
886 CEREBRAL INFARCTION 10 0.0004
887 FEAR 11 0.0004
888 NIGHTMARE 14 0.0004
889 RHINORRHOEA 26 0.0004
890 APPLICATION SITE PRURITUS 9 0.0004
891 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
892 INTENTIONAL OVERDOSE 25 0.0004
893 ERECTILE DYSFUNCTION 10 0.0004
894 EMOTIONAL DISORDER 12 0.0004
895 INFLUENZA LIKE ILLNESS 32 0.0004
896 INTENTIONAL PRODUCT MISUSE 34 0.0004
897 PAIN IN JAW 11 0.0004
898 UNRESPONSIVE TO STIMULI 10 0.0004
899 TOOTH LOSS 8 0.0004
900 HALLUCINATION 29 0.0004
901 NERVOUSNESS 20 0.0004
902 ACCIDENTAL OVERDOSE 14 0.0004
903 RESTLESSNESS 14 0.0004
904 PRODUCT SUBSTITUTION ISSUE 22 0.0004
905 INJECTION SITE MASS 14 0.0004
906 INFLUENZA 42 0.0004
907 MULTIPLE SCLEROSIS 18 0.0004
908 EATING DISORDER 8 0.0004
909 HYPOGLYCAEMIA 18 0.0004
910 ATRIAL FIBRILLATION 36 0.0004
911 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
912 IRRITABILITY 22 0.0004
913 BLOOD POTASSIUM DECREASED 11 0.0004
914 FLUSHING 37 0.0004
915 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
916 HOT FLUSH 27 0.0004
917 EYE PRURITUS 12 0.0004
918 SNEEZING 8 0.0004
919 PRODUCT COMPLAINT 9 0.0004
920 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 64 0.0004
921 HYPONATRAEMIA 20 0.0004
922 FLATULENCE 20 0.0004
923 THERAPY INTERRUPTED 25 0.0003
924 RENAL DISORDER 16 0.0003
925 ILLNESS 35 0.0003
926 CARDIAC FAILURE 27 0.0003
927 POLLAKIURIA 14 0.0003
928 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
929 CORONARY ARTERY DISEASE 10 0.0003
930 URINARY RETENTION 11 0.0003
931 DISORIENTATION 13 0.0003
932 INJECTION SITE SWELLING 25 0.0003
933 TREMOR 54 0.0003
934 SPEECH DISORDER 17 0.0003
935 PNEUMONIA ASPIRATION 8 0.0003
936 LOSS OF CONSCIOUSNESS 41 0.0003
937 PLATELET COUNT DECREASED 34 0.0003
938 LUNG NEOPLASM MALIGNANT 13 0.0003
939 CARDIO-RESPIRATORY ARREST 13 0.0003
940 AGGRESSION 15 0.0003
941 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
942 ARRHYTHMIA 14 0.0003
943 MOOD ALTERED 8 0.0003
944 NO ADVERSE EVENT 53 0.0003
945 COMPLETED SUICIDE 24 0.0003
946 NEOPLASM PROGRESSION 10 0.0003
947 AGITATION 21 0.0003
948 PRODUCT DOSE OMISSION ISSUE 84 0.0003
949 HEART RATE DECREASED 10 0.0003
950 HEAD INJURY 9 0.0003
951 DRUG DOSE OMISSION 47 0.0003
952 EPISTAXIS 21 0.0003
953 INTENTIONAL DOSE OMISSION 8 0.0003
954 HIP FRACTURE 9 0.0003
955 CONVULSION 16 0.0003
956 DRUG EFFECT DECREASED 15 0.0003
957 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
958 DEATH 236 0.0003
959 ACUTE MYOCARDIAL INFARCTION 8 0.0003
960 VISUAL ACUITY REDUCED 9 0.0003
961 PSYCHOTIC DISORDER 8 0.0003
962 CARDIAC FAILURE CONGESTIVE 21 0.0003
963 CEREBROVASCULAR ACCIDENT 44 0.0003
964 INCORRECT DOSE ADMINISTERED 58 0.0003
965 DEVICE DISLOCATION 11 0.0003
966 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
967 DEVICE BREAKAGE 10 0.0002
968 HAEMORRHAGE 25 0.0002
969 COMA 11 0.0002
970 PLASMA CELL MYELOMA 9 0.0002
971 MYELOSUPPRESSION 8 0.0002
972 DEVICE EXPULSION 14 0.0002
973 BLOOD GLUCOSE DECREASED 10 0.0002
974 DRUG DEPENDENCE 32 0.0002
975 INJECTION SITE PRURITUS 13 0.0002
976 CARDIAC DISORDER 18 0.0002
977 INJECTION SITE PAIN 59 0.0002
978 BRADYCARDIA 10 0.0002
979 INJECTION SITE BRUISING 15 0.0002
980 INJECTION SITE HAEMORRHAGE 15 0.0002
981 DEVICE MALFUNCTION 12 0.0002
982 BLOOD GLUCOSE INCREASED 32 0.0002
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
984 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
985 INJECTION SITE ERYTHEMA 18 0.0001
986 DEVICE ISSUE 12 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
988 PRODUCT STORAGE ERROR 11 0.0001
989 BREAST CANCER 10 0.0001
990 DRUG WITHDRAWAL SYNDROME 9 0.0001